Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adenosine A3 receptor | Starlite/ChEMBL | References |
Homo sapiens | adenosine A2b receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.3737 | 0.5 |
Onchocerca volvulus | 0.0026 | 0.4235 | 0.5 | |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.3737 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 1 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0026 | 0.4235 | 0.3973 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.3737 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.3737 | 0.5 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0014 | 0.0435 | 0.0435 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0026 | 0.4235 | 0.4235 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 1 | 1 |
Echinococcus multilocularis | lamin dm0 | 0.0026 | 0.4235 | 0.4235 |
Echinococcus multilocularis | lamin | 0.0026 | 0.4235 | 0.4235 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.3737 | 0.3737 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.3737 | 0.5 |
Onchocerca volvulus | 0.0026 | 0.4235 | 0.5 | |
Brugia malayi | intermediate filament protein | 0.0026 | 0.4235 | 0.3973 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.3737 | 0.5 |
Brugia malayi | hypothetical protein | 0.0025 | 0.3737 | 0.3453 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.3737 | 0.5 |
Brugia malayi | hypothetical protein | 0.0016 | 0.1013 | 0.0604 |
Loa Loa (eye worm) | intermediate filament protein | 0.0026 | 0.4235 | 0.4235 |
Echinococcus granulosus | intermediate filament protein | 0.0026 | 0.4235 | 0.4235 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 1 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0025 | 0.3737 | 0.5 |
Echinococcus multilocularis | musashi | 0.0026 | 0.4235 | 0.4235 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.4235 | 0.4235 |
Echinococcus granulosus | lamin | 0.0026 | 0.4235 | 0.4235 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.4085 | 0.4085 |
Echinococcus granulosus | lamin dm0 | 0.0026 | 0.4235 | 0.4235 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0045 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 5.9 nM | Displacement of [3H]NECA from human recombinant adenosine A3 receptor expressed in CHO cells after 3 hrs | ChEMBL. | 21908194 |
Ki (functional) | > 10000 nM | Antagonist activity human recombinant adenosine 2B receptor expressed in CHO cells assessed as inhibition of NECA-stimulated adenylyl cyclase activity | ChEMBL. | 21908194 |
Ki (binding) | > 30000 nM | Displacement of [3H]CCPA from human recombinant adenosine A1 receptor expressed in CHO cells after 3 hrs | ChEMBL. | 21908194 |
Ki (binding) | > 30000 nM | Displacement of [3H]NECA from human recombinant adenosine 2A receptor expressed in CHO cells after 3 hrs | ChEMBL. | 21908194 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.